Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity of Pneumococcal and Influenza Vaccines in RA Patients Treated with Certolizumab Pegol
NCT00993668Phase 4Completed
- Sponsor
- UCB
- Start
- Sep 2009
- Primary completion
- Jun 2010
- Modality
- Antibody Fragments, Polymer-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 4 trial of certolizumab pegol in rheumatoid arthritis (RA), sponsored by UCB. Started Sep 2009; status: completed.
02
Drugs
certolizumab pegol
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00993668.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00993668.